• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>IMS Health

IMS Health

Putnam Investors A PINVX 2 Star

Last Price$23.61Day Change (%)0.47%
Open Price$23.61Day Change ($)0.11
Day Range23.61–23.6152-Week Range18.49–23.61

As of Sat 12/09/2016 | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Drug-Research Firm PPD Explores Sale

    Drug-Research Firm PPD Explores Sale

  2. Dr. Reddy's Laboratories Announces the Launch of Nystatin and Triamcinolone Acetonide Cream, USP in the U.S. Market

    Dr. Reddy's Laboratories Announces the Launch of Nystatin and Triamcinolone Acetonide Cream, USP in the U.S. Market

  3. Innovus Pharma Launches its Clinically Proven UriVarx™ Product for Bladder Health Through its Beyond Human® Sales and Marketing Platform in the United States

    Innovus Pharma Launches its Clinically Proven UriVarx™ Product for Bladder Health Through its Beyond Human® Sales and Marketing Platform in the United States

  4. Lupin Receives FDA Approval for Generic Nuvigil® Tablets

    Lupin Receives FDA Approval for Generic Nuvigil® Tablets

  5. Drugmakers Find Competition Doesn't Keep a Lid on Prices

    Drugmakers Find Competition Doesn't Keep a Lid on Prices

  6. Our Take on the Second Quarter

    Despite the Fed taper, a U.S. economy struggling to shake off the winter blues, and a slowing China, stocks continued their remarkable winning streak from April through June.

  7. Trouble in Plain Sight

    IMS Health is on the right track for growth.

  8. Our Take on the Fourth Quarter

    A look back at the winners and losers of the final quarter of a tumultuous year.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.